Eight individuals (6.2%) had died after their last follow-up; four had SCN1A-related Dravet syndrome; the others had CHD2, GNAO1, KCNT1 and NEXMIF-related DEEs. Here, CHD2 is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.